Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Adcock Ingram Holdings ZAR 4.89B 194.86M 2024-06
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Celltrion KRW 5.37T 121.47B 2024-09
Cspc Pharmaceutical CNY 26.47B 278.69M 2024-06
Dianthus Therapeutics USD 287.49M 78.2M 2024-09
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
Incyte USD 3.24B 430.32M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Kangmei Pharma CNY 7.01B 15.81M 2024-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 540.78M 55.36M 2024-06
Malin Corporation EUR 35.9M 100K 2024-06
Moderna USD 8.1B 1.57B 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Pharma Mar EUR 250.25M 12.23M 2024-12
Qiagen NV USD 1.96B 494.22M 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Sartorius EUR 1.97B 114.6M 2024-09
Sino Biopharmaceutical CNY 25.22B 1.42B 2024-06
Tilray USD 707.34M 18.54M 2024-11
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Zz Pientze Pharmaceu 15.84B 718.65M 2024-09



Moderna Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.